260 related articles for article (PubMed ID: 24898696)
1. Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Cα in epithelial ovarian cancer.
Qi H; Sun B; Zhao X; Du J; Gu Q; Liu Y; Cheng R; Dong X
Oncol Rep; 2014 Aug; 32(2):771-9. PubMed ID: 24898696
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y
Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
[TBL] [Abstract][Full Text] [Related]
3. The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer.
Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V
Gynecol Oncol; 2014 Aug; 134(2):338-45. PubMed ID: 24924122
[TBL] [Abstract][Full Text] [Related]
4. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
[TBL] [Abstract][Full Text] [Related]
5. Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition.
Ren D; Minami Y; Nishita M
Genes Cells; 2011 Mar; 16(3):304-15. PubMed ID: 21342370
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells.
Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M
BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409
[TBL] [Abstract][Full Text] [Related]
7. Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.
Bitler BG; Nicodemus JP; Li H; Cai Q; Wu H; Hua X; Li T; Birrer MJ; Godwin AK; Cairns P; Zhang R
Cancer Res; 2011 Oct; 71(19):6184-94. PubMed ID: 21816908
[TBL] [Abstract][Full Text] [Related]
8. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT
J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.
Burkhalter RJ; Westfall SD; Liu Y; Stack MS
J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151
[TBL] [Abstract][Full Text] [Related]
10. EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells.
Zhang Y; Du J; Zheng J; Liu J; Xu R; Shen T; Zhu Y; Chang J; Wang H; Zhang Z; Meng F; Wang Y; Chen Y; Xu Y; Gu L
Oncotarget; 2015 Mar; 6(9):7244-61. PubMed ID: 25779663
[TBL] [Abstract][Full Text] [Related]
11. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
[TBL] [Abstract][Full Text] [Related]
12. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
13. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S
Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283
[TBL] [Abstract][Full Text] [Related]
14. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer.
Wang B; Tang Z; Gong H; Zhu L; Liu X
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966
[TBL] [Abstract][Full Text] [Related]
15. Effect of WNT5A on epithelial-mesenchymal transition and its correlation with tumor invasion and metastasis in nasopharyngeal carcinoma.
Zhu HH; Zhu XY; Zhou MH; Cheng GY; Lou WH
Asian Pac J Trop Med; 2014 Jun; 7(6):488-91. PubMed ID: 25066400
[TBL] [Abstract][Full Text] [Related]
16. cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer.
Tang J; Wang J; Fan L; Li X; Liu N; Luo W; Wang J; Wang Y; Wang Y
Oncotarget; 2016 Apr; 7(17):24050-62. PubMed ID: 26992227
[TBL] [Abstract][Full Text] [Related]
17. Wnt5a influences viability, migration, adhesion, colony formation, E- and N-cadherin expression of human ovarian cancer cell line SKOV-3.
Jannesari-Ladani F; Hossein G; Monhasery N; Shahoei SH; Izadi Mood N
Folia Biol (Praha); 2014; 60(2):57-67. PubMed ID: 24785108
[TBL] [Abstract][Full Text] [Related]
18. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between bacterial L-form infection, expression of HIF-1α/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer].
Yu L; Wu SW; Zhou L; Song WQ
Sheng Li Xue Bao; 2012 Dec; 64(6):657-65. PubMed ID: 23258329
[TBL] [Abstract][Full Text] [Related]
20. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells.
Kanzawa M; Semba S; Hara S; Itoh T; Yokozaki H
Pathobiology; 2013; 80(5):235-44. PubMed ID: 23615002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
